The company also announced that it has been awarded grant funding from Parkinson’s UK to support evaluation of Pretzel’s POLG activation mechanism in Parkinson's disease models in collaboration with ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

Aprea Therapeutics has dosed a subject with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) ...

Cash, cash equivalents and marketable securities as of December 31, 2024 totaled $27.6M, compared to $48.5M for the year ended December 31, ...

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company ...

Trial achieved key objectives for safety, tolerability, pharmacokinetics and pharmacodynamicsClinical data from this trial, together with ...

ProMIS expects to report six-month interim results from PRECISE-AD in the first half of 2026, with topline results ...